Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
J Cell Sci ; 121(Pt 16): 2696-704, 2008 Aug 15.
Artigo em Inglês | MEDLINE | ID: mdl-18653538

RESUMO

Newly deposited microfibrils strongly colocalise with fibronectin in primary fibroblasts. Microfibril formation is grossly inhibited by fibronectin depletion, but rescued by supplementation with exogenous cellular fibronectin. As integrin receptors are key determinants of fibronectin assembly, we investigated whether they also influenced microfibril deposition. Analysis of beta1-integrin-receptor-null fibroblasts, blockage of cell surface integrin receptors that regulate fibronectin assembly and disruption of Rho kinase all result in suppressed deposition of both fibronectin and microfibrils. Antibody activation of beta1 integrins in fibronectin-depleted cultures is insufficient to rescue microfibril assembly. In fibronectin(RGE/RGE) mutant mouse fibroblast cultures, which do not engage alpha5beta1 integrin, extracellular assembly of both fibronectin and microfibrils is markedly reduced. Thus, pericellular microfibril assembly is regulated by fibronectin fibrillogenesis.


Assuntos
Fibronectinas/metabolismo , Fibronectinas/fisiologia , Microfibrilas/metabolismo , Proteínas dos Microfilamentos/metabolismo , Animais , Células Cultivadas , Fibrilina-1 , Fibrilinas , Fibroblastos/metabolismo , Fibronectinas/antagonistas & inibidores , Humanos , Integrina alfa5beta1/antagonistas & inibidores , Integrina alfa5beta1/fisiologia , Integrina beta1/genética , Integrina beta1/metabolismo , Camundongos , Microfibrilas/efeitos dos fármacos , Modelos Biológicos , Polímeros/metabolismo , Ligação Proteica/efeitos dos fármacos , RNA Interferente Pequeno/farmacologia
2.
FASEB J ; 18(9): 1034-6, 2004 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-15059975

RESUMO

The first step in the generation of the amyloid-beta peptide (Abeta) deposited in the brains of patients with Alzheimer's disease (AD) is the processing of the larger Abeta precursor protein (APP) by an integral membrane aspartyl protease named the beta-site APP-cleaving enzyme (BACE). We present the genomic organization of the BACE gene. BACE mRNAs are synthesized as nine exons and eight introns from a 30.6 kb region of chromosome 11q23.2-11q23.3. Regulation of BACE may play an important role in regulating the levels of Abeta produced and is therefore likely to play an important role in AD. Herein, we report the cloning and detailed analysis of 3765 nucleotides of the promoter region of BACE and 364 nucleotides of the 5' untranslated region of the BACE mRNA (5' UTR). Characteristic "CAAT" and "TATA" boxes are absent within 1.5 kb of the transcription start site (TSS). The promoter region and 5' UTR contain multiple transcription factor binding sites, such as activator protein (AP)1, AP2, cAMP response element binding protein (CREB), estrogen responsive element (ERE), glucocorticoid responsive element (GRE), "GC" box, nuclear factor (NF)-kappaB, signal transducer and activator of transcription (STAT)1, stimulating protein (SP)1, metal-regulatory elements, and possible Zeste binding sites. Limited interspecies similarity was observed between the human sequence and corresponding genomic DNA from the rat and mouse sequences, but several transcription factor-binding sites are conserved. Thus, the BACE gene contains basal regulatory elements, inducible features and sites for regulated activity by various transcription factors. These results identify the important regions for functional analysis of the binding domains and neuron-specific expression (1). Such a study will allow us to further examine the possible role of changes in the promoter of BACE in AD pathogenesis.


Assuntos
Regiões 5' não Traduzidas/genética , Endopeptidases/genética , Regiões Promotoras Genéticas/genética , Região 5'-Flanqueadora/genética , Doença de Alzheimer , Secretases da Proteína Precursora do Amiloide , Animais , Ácido Aspártico Endopeptidases , Composição de Bases , Sequência de Bases , Sítios de Ligação , Cromossomos Humanos Par 11/genética , Clonagem Molecular , Sequência Consenso/genética , Éxons/genética , Genômica , Humanos , Íntrons/genética , Camundongos , Dados de Sequência Molecular , Ratos , Elementos de Resposta/genética , Mapeamento por Restrição , Fatores de Transcrição/metabolismo , Sítio de Iniciação de Transcrição
3.
J Mol Neurosci ; 19(1-2): 31-5, 2002.
Artigo em Inglês | MEDLINE | ID: mdl-12212790

RESUMO

The Alzheimer's amyloid beta protein (A beta) precursor (APP) is proteolytically cleaved by beta-secretase to N- and C-terminal fragments sAPPbeta and CTFbeta, respectively. Subsequently, CTFbeta is cleaved by gamma-secretase to generate A beta. We previously showed that the levels of secreted A beta and sAPPbeta were significantly reduced upon removal of glycosylphosphatidylinositol (GPI)-anchored proteins from either primary brain cells or Chinese hamster ovary cultures. The results indicated that GPI-anchored proteins facilitated beta-secretase activity. In this report, we strengthen the previous findings by demonstrating that CTFbeta, like sAPPbeta, is also reduced upon removal of GPI-anchored proteins and that sAPPbeta does not accumulate in an intracellular compartment. This facilitation pathway does not appear to be important for the processing of a disease-linked mutant form of APP (670NL), known to be a superior beta-secretase substrate. A novel aspartyl protease, BACE, responsible for beta-secretase activity in the brain is not GPI-anchored. However, BACE in brain membranes accumulate in lipid rafts, a compartment marked by the accumulation of GPI-anchored proteins. This finding is consistent with the hypothesis that BACE interacts with GPI-anchored proteins that facilitate its activity possibly by chaperoning it into lipid rafts.


Assuntos
Doença de Alzheimer/metabolismo , Peptídeos beta-Amiloides/biossíntese , Precursor de Proteína beta-Amiloide/metabolismo , Ácido Aspártico Endopeptidases/metabolismo , Encéfalo/metabolismo , Endopeptidases/metabolismo , Glicosilfosfatidilinositóis/metabolismo , Microdomínios da Membrana/metabolismo , Doença de Alzheimer/enzimologia , Secretases da Proteína Precursora do Amiloide , Animais , Encéfalo/enzimologia , Células CHO , Células Cultivadas , Cricetinae , Cobaias , Humanos , Microdomínios da Membrana/enzimologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...